@Companyresearch
Painchek - FDA for a De novo device. clinical study took 14months including the report writing.
Botanix - Topical drug for hyperhidrosis. FDA approved. Took 12 months for phase 3.
Resapp FDA rejected. Device for upset repository tract detection. Took 12 months for phase 3
All 3 companies above also quoted unrealistic expectations to share holders for trial completion.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
0.010(4.65%) |
Mkt cap ! $145.1M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 21.3¢ | $1.052M | 4.823M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80000 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 336102 | 11 |
View Market Depth
| Last trade - 15.44pm 18/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |